Research indicates that BPA exposure in pregnant women is linked to complications such as pre-eclampsia and gestational diabetes, as well as adverse birth outcomes like preterm delivery and lower birth weights.

The review also includes a detailed methodology section, outlining the criteria for selecting 58 relevant studies from databases such as PubMed and Scopus.

The narrative review synthesizes a decade's worth of epidemiological and experimental studies, revealing associations between BPA exposure and immune system impairments, respiratory diseases like asthma, and neurodevelopmental issues in children, including autism and behavioral changes.

In light of the higher exposure levels found in pregnant women compared to the general population, the authors advocate for stricter regulations on BPA use during pregnancy to mitigate health risks.

The review highlights the pervasive nature of BPA in consumer products, such as food containers and thermal paper, raising serious public health concerns.

BPA is known for its endocrine-disrupting properties, which can interfere with hormonal functions, posing long-term risks to both maternal and foetal health, particularly since the foetus cannot effectively eliminate BPA.

These findings underscore the urgent need for further research into the impacts of BPA and its substitutes to better safeguard public health.

Current legislation may fall short in protecting against the risks posed by BPA during pregnancy, necessitating a reevaluation of acceptable daily intake levels.

A recent article by Henrique Eloi Costa and colleagues from the University of Beira Interior examines the significant health risks associated with bisphenol A (BPA) exposure in pregnant women and their developing foetuses.